Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 14,771 | 17,652 | 15,942 | -34,473 | 6,267 |
| Operating Income | -14,771 | -17,652 | -15,942 | 34,473 | -6,267 |
| Other Income | 38 | 245 | 70 | 35 | -21 |
| Pre-tax Income | -14,733 | -17,407 | -15,873 | 34,508 | -6,288 |
| Income Tax | 9 | 9 | -7 | N/A | N/A |
| Net Income Continuous | -14,742 | -17,416 | -15,866 | 34,508 | -6,288 |
| Minority Interests | N/A | -5,262 | N/A | N/A | N/A |
| Net Income | $-14,742 | $-12,154 | $-15,880 | $34,508 | $-6,288 |
| EPS Basic Total Ops | -0.27 | -0.34 | -3.17 | 5.25 | -2.63 |
| EPS Basic Continuous Ops | -0.40 | -0.49 | -3.16 | 3.97 | -2.63 |
| EPS Diluted Total Ops | -0.27 | -0.34 | -3.17 | 5.25 | -2.63 |
| EPS Diluted Continuous Ops | -0.40 | -0.49 | -3.16 | 3.97 | -2.63 |
| EBITDA(a) | $-14,767 | $-17,649 | $-15,940 | $34,473 | $-6,265 |